CLASS ACTION UPDATE for CELH, GRAB and ABBV: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders Pharmaceutical Investing
SHAREHOLDER ALERT: MP CELH ABBV: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines Pharmaceutical Investing
LAWSUITS FILED AGAINST TASK, CELH and ABBV - Jakubowitz Law Pursues Shareholders Claims Pharmaceutical Investing
INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of AbbVie Inc. Investors Pharmaceutical Investing
ABBV CLASS ACTION NOTICE: Kessler Topaz Meltzer & Check, LLP Announces to AbbVie, Inc. Investors of Deadline in Securities Fraud Class Action Lawsuit Pharmaceutical Investing
Merck Announces U.S. FDA has Granted Breakthrough Therapy Designation for V116, the Company's Investigational 21-Valent Pneumococcal Conjugate Vaccine, for the Prevention of Invasive Pneumococcal Disease and Pneumococcal Pneumonia in Adults Life Science Investing
Pfizer and BioNTech Announce Data Demonstrating High Immune Response Following a Booster Dose of their COVID-19 Vaccine in Children 5 Through 11 Years of Age Life Science Investing
Moore Kuehn, PLLC Encourages Investors of AbbVie Inc. or International Business Machines Corporation to Contact Law Firm Pharmaceutical Investing
AbbVie and Genmab Announce Topline Results for Epcoritamab from Phase 1/2 Trial in Patients with Relapsed/Refractory Large B-cell Lymphoma Pharmaceutical Investing
Important Investor Reminder: Kessler Topaz Meltzer & Check, LLP Reminds AbbVie, Inc. Investors of Deadline in Securities Fraud Class Action Lawsuit and Encourages Investors with Significant Losses to Contact the Firm Pharmaceutical Investing
